SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (217)5/18/1997 1:01:00 PM
From: luis a. garcia   of 1115
 
Thank you John for the great post. LIDAK will come through on both major phase III studies for oral and genital herpes applications and now with Kaposi Sarcoma showing this much promise the company with a good cash position qtr ended with a loss of .11 vs expected higher I thought someone said .17 ...things are shaping up very nicely.
Insider selling reported this month was only 10k from katz who owns over a million shares... so the big insider sell off never came off as people feared.. hey lets be optimistic going forward all right!
allright! I think I need to look at how long before Kaposi is out of phase two and starts phase III. Why can't they start getting phase three going?? based on this results? In for a penny In for a pound?
Or do you suppose the FDA will gate them in a serial fashion as to when phase III is approved to start???
Like I said scalping is fun however if LIDAKOL derivative is effective
against Kaposi we may have a longer term play in the works and premature selling may be unwise.. More information is needed ... there is still time... so Manana turns into next Manana..

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext